UBS Group’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-320,038
| Closed | -$7.71M | – | 9072 |
|
|
2023
Q1 | $7.71M | Buy |
320,038
+276,789
| +640% | +$6.67M | ﹤0.01% | 1531 |
|
|
2022
Q4 | $457K | Buy |
43,249
+11,297
| +35% | +$119K | ﹤0.01% | 3766 |
|
|
2022
Q3 | $144K | Sell |
31,952
-326
| -1% | -$1.47K | ﹤0.01% | 4362 |
|
|
2022
Q2 | $129K | Sell |
32,278
-3,340
| -9% | -$13.3K | ﹤0.01% | 4247 |
|
|
2022
Q1 | $261K | Sell |
35,618
-2,258
| -6% | -$16.5K | ﹤0.01% | 4197 |
|
|
2021
Q4 | $213K | Buy |
37,876
+3,403
| +10% | +$19.1K | ﹤0.01% | 4593 |
|
|
2021
Q3 | $221K | Sell |
34,473
-2,555
| -7% | -$16.4K | ﹤0.01% | 4199 |
|
|
2021
Q2 | $312K | Sell |
37,028
-8,965
| -19% | -$75.5K | ﹤0.01% | 4059 |
|
|
2021
Q1 | $483K | Buy |
45,993
+10,997
| +31% | +$115K | ﹤0.01% | 3955 |
|
|
2020
Q4 | $593K | Sell |
34,996
-8,006
| -19% | -$136K | ﹤0.01% | 3570 |
|
|
2020
Q3 | $551K | Sell |
43,002
-3,791
| -8% | -$48.6K | ﹤0.01% | 3336 |
|
|
2020
Q2 | $660K | Buy |
46,793
+20,958
| +81% | +$296K | ﹤0.01% | 3178 |
|
|
2020
Q1 | $238K | Buy |
25,835
+4,996
| +24% | +$46K | ﹤0.01% | 3770 |
|
|
2019
Q4 | $311K | Buy |
20,839
+8,470
| +68% | +$126K | ﹤0.01% | 4275 |
|
|
2019
Q3 | $84K | Buy |
+12,369
| New | +$84K | ﹤0.01% | 4941 |
|
|
2018
Q4 | – | Sell |
-2,850
| Closed | -$11K | – | 7299 |
|
|
2018
Q3 | $11K | Buy |
+2,850
| New | +$11K | ﹤0.01% | 6215 |
|